Skip to main content
# Title Research Year
61 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
62 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
63 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
64 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
65 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
66 The Efficacy of Denosumab versus Zoledronic Acid in Preventing
Skeletal Related Events in Cancer Patients with Bone Metastasis
2017
67 Technetium-99m pentavalent dimercaptosuccinic acid (99mTc-DMSA-V) brain SPECT/CT and Karnofsky performance score predict survival in patients with glioma 2017
68 Prognostic Factors in Advanced Non-Small Cell Lung
Cancer and Their Relation to Clinical Outcomes
2017
69 Brain SPECT/CT scanning with technetium-99m pentavalent dimercaptosuccinic acid [DMSA (V)] is an accurate tool for post-treatment evaluation of patients with glioma. 2017
70 Survival of High Grade Glioma Patients Treated by Three Radiation Schedules
with Chemotherapy: A Retrospective Comparative Study
2017